Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

[Analysis of clinical characteristics and variant of NKX2-1 gene in a Chinese boy with Brain-Lung-Thyroid syndrome]

Targeted Sequencing Identifies A Novel Sh2d1a Pathogenic Variant In A Chinese Family: Carrier Screening And Prenatal Genetic Testing

A Novel Missense Variant in the NKX2-1 Homeodomain Prevents Transcriptional Rescue by TAZ

[Report of a child with Bainbridge-Ropers syndrome due to a novel variant of ASXL3 gene and a literature review]

Case report: A novel TLK2 variant with a neuropsychiatric phenotype from a Chinese family

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

[Genetic and clinical analysis of a child with Shwachman-Diamond syndrome due to compound heterozygous variants of SBDS gene]

Identification of Novel KMT2D Mutations in Two Chinese Children with Kabuki Syndrome: a Case Report and Systematic Literature Review

Genetic analysis and prenatal diagnosis for a Chinese pedigree affected with Bainbridge-Ropers syndrome

[Clinical and genetic analysis of a Chinese pedigree affected with type 2 Long QT syndrome due to variant of KCNH2 gene]

[Clinical and genetic analysis of two children with TANC2 gene variants and a literature review]

Systematic review of thyroid function in NKX2-1-related disorders: Screening and diagnosis

Case Report: A Study on the De Novo KMT2D Variant of Kabuki Syndrome with Goodpasture’s Syndrome by Whole Exome Sequencing

Novel germline variants in KMT2C in Chinese patients with Kleefstra syndrome-2

Case report: A novel truncating variant of BCL11B associated with rare feature of craniosynostosis and global developmental delay.

Biliary, Renal, Neurological, and Skeletal Syndrome in a Chinese Boy

Expanding the genotypic and phenotypic spectrum associated with TBL1XR1 de novo variants

[Identification of a Child with Teebi Hypertelorism Syndrome 1 Due to Variant of SPECC1L Gene].

[Clinical and genetic analysis of a child with West syndrome due to a de novo variant of NEXMIF gene]

Truncating mutation in TANC2 in a Chinese boy associated with Lennox-Gastaut syndrome: a case report

[Identification of a novel TBR1 gene variant in a Chinese pedigree affected with intellectual developmental disorder with autism and speech delay]